Αποτελέσματα Αναζήτησης
8 Απρ 2020 · The aim of this rapid review was to summarise the evidence on the potential duration of patient infectiousness, as derived from virus culture and contact tracing studies, for those individuals in whom SARS-CoV-2 RNA is detected, and hence inform guidance on the duration of isolation.
- Open in a Separate Window
To summarise the evidence on the duration of infectiousness...
- Open in a Separate Window
9 Αυγ 2021 · It was estimated that 80% of the infected patients with SARS-CoV-2 developed one or more long-term symptoms. The five most common symptoms were fatigue (58%), headache (44%), attention...
19 Οκτ 2021 · A retrospective analysis of basic immune parameters comparing 25 individuals with asymptomatic infection with 27 individuals with symptomatic infection found similar levels of...
11 Νοε 2022 · Infection with SARS-CoV-2 virus is associated with a wide range of symptoms. The REal-time Assessment of Community Transmission − 1 (REACT-1) study monitored the spread and clinical...
13 Μαΐ 2020 · The main symptoms of COVID‐19 are fever, cough, fatigue, slight dyspnoea, sore throat, headache, conjunctivitis and gastrointestinal issues. Real‐time PCR is used as a diagnostic tool using nasal swab, tracheal aspirate or bronchoalveolar lavage samples. Computed tomography findings are important for both diagnosis and follow‐up.
6 Οκτ 2020 · Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a highly transmissible and pathogenic coronavirus that emerged in late 2019 and has caused a pandemic of acute respiratory disease, named ‘coronavirus disease 2019’ (COVID-19), which threatens human health and public safety.
17 Ιουλ 2024 · We prespecified a list of health outcomes that have been previously described as postacute sequelae of SARS-CoV-2 infection (Table S2). 1,6–12 Outcomes were defined on the basis of multiple data ...
